Axsome Therapeutics, Inc. (AXSM) ownership: insiders 1% · institutions 70% · index and ETF funds 6% (13F 2026-03-31). Insider activity, 90 days: Routine (13 sales, 0 open-market buys). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Vanguard | 4354876.00 | $736.06M | 8.3% | 2026-03-31 |
| BlackRock | 3912844.00 | $661.35M | 7.5% | 2026-03-31 |
| FMR (Fidelity) | 1566995.00 | $264.85M | 3.0% | 2026-03-31 |
| Invesco | 1297678.00 | $219.33M | 2.5% | 2026-03-31 |
| Geode Capital Management | 1162981.00 | $196.60M | 2.2% | 2026-03-31 |
| Wellington Management | 1145306.00 | $193.58M | 2.2% | 2026-03-31 |
| Deep Track Capital, LP | 1100000.00 | $185.92M | 2.1% | 2026-03-31 |
| State Street | 986809.00 | $166.79M | 1.9% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-07-01 |
Back to AXSM overview · AXSM earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.